Inhaled corticosteroids in severe COPD patients with cardiovascular diseases. Authors’ reply
-
Published:2024-08
Issue:
Volume:
Page:
-
ISSN:0953-6205
-
Container-title:European Journal of Internal Medicine
-
language:en
-
Short-container-title:European Journal of Internal Medicine
Author:
Papi Alberto,
Forini Giacomo,
Maniscalco Mauro,
Aliani Maria,
Fabbri Leonardo MORCID
Reference13 articles.
1. Long-term inhaled corticosteroid treatment in patients with chronic obstructive lung disease, cardiovascular disease, and recent hospitalization for exacerbation;Pruc;Eur J Intern Med,2024
2. Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: the ICSLIFE pragmatic, randomised controlled study;Papi;Eur J Intern Med,2024
3. Comparing randomized controlled trials and real-world studies in chronic obstructive pulmonary disease pharmacotherapy;Tashkin;Int J Chron Obstruct Pulmon Dis,2020
4. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019;Singh;Eur Respir J,2019
5. Comparative safety and effectiveness of inhaled corticosteroid and long-acting beta(2)-agonist combinations in patients with COPD;Chang;Chest,2020